BMC Infectious Diseases

OCT 21, 2026 · JOURNAL ARTICLE

Tracking infections in Belgian long-term care facilities: a one-year prospective study of incidence, duration, and clinical outcomes

BMC Infectious Diseases

Healthcare-associated infections (HAIs) are a public health issue in long-term care facilities (LTCFs), particularly among older adults. While European point prevalence surveys hav

OCT 20, 2026 · JOURNAL ARTICLE

Early C-reactive protein dynamics are associated with antibiotic therapy appropriateness in patients with bacteremia

BMC Infectious Diseases

Abstract Background Inappropriate antibiotic therapy poses a significant health risk, contributing to antibiotic resistance, unfavourable prognosis, and escalated hospitalization c

OCT 17, 2026 · JOURNAL ARTICLE

Clinical and epidemiological characterization of patients with HIV/AIDS in Shiraz, Iran

BMC Infectious Diseases

The human immunodeficiency virus (HIV) pandemic remains a major global health challenge. Iran, a country in the Middle East and North Africa (MENA) region, is facing a growing burd

OCT 12, 2026 · JOURNAL ARTICLE

Mpox and Varicella Zoster Virus coinfection in endemic and outbreak settings: a systematic review and meta-analysis

BMC Infectious Diseases

Abstract Background MPOX-VZV co-infection poses diagnostic challenges and public health implications due to the overlap in clinical presentation and complications. Evidence on the

OCT 10, 2026 · JOURNAL ARTICLE

Case report: hemophagocytic lymphohistiocytosis secondary to bartonella henselae bacteremia in a renal transplant recipient

BMC Infectious Diseases

Abstract Background Bartonella henselae can cause disseminated infection in renal transplant recipients, however, cases presenting with hemophagocytic lymphohistiocytosis (HLH) tri

SEP 30, 2026 · JOURNAL ARTICLE

Long-term metabolic changes after switching from TDF/3TC/EFV to BIC/FTC/TAF or DTG/3TC in people living with HIV: a retrospective comparative cohort study in China

BMC Infectious Diseases

The metabolic consequences of switching from tenofovir disoproxil fumarate + lamivudine + efavirenz (TDF+3TC + EFV) to newer integrase strand transfer inhibitor (INSTI)-based regim

SEP 30, 2026 · JOURNAL ARTICLE

Epidemiology and clinical impact of macrolide-resistant Mycoplasma pneumoniae in Singapore – findings from a multicentre surveillance programme

BMC Infectious Diseases

Mycoplasma pneumoniae is a leading cause of community-acquired pneumonia worldwide. Due to intrinsic beta-lactam resistance, macrolides are recommended as first-line treatment. How

SEP 28, 2026 · JOURNAL ARTICLE

The prevalence of and factors associated with hepatitis B and hepatitis C among men who have sex with men in Kigali, Rwanda

BMC Infectious Diseases

Rwanda has scaled up its viral hepatitis B (HBV) and C (HCV) prevention and treatment programs over the last decade. However, data to guide HBV and HCV programming for men who have